Contribution of the α5 nAChR Subunit and α5SNP to Nicotine-Induced Proliferation and Migration of Human Cancer Cells

Nicotine in tobacco is known to induce tumor-promoting effects and cause chemotherapy resistance through the activation of nicotinic acetylcholine receptors (nAChRs). Many studies have associated the α5 nicotinic receptor subunit (α5), and a specific polymorphism in this subunit, with (i) nicotine administration, (ii) nicotine dependence, and (iii) lung cancer. The α5 gene CHRNA5 mRNA is upregulated in several types of cancer, including lung, prostate, colorectal, and stomach cancer, and cancer severity is correlated with smoking. In this study, we investigate the contribution of α5 in the nicotine-induced cancer hallmark functions proliferation and migration, in breast, colon, and prostate cancer cells. Nine human cell lines from different origins were used to determine nAChR subunit expression levels. Then, selected breast (MCF7), colon (SW480), and prostate (DU145) cancer cell lines were used to investigate the nicotine-induced effects mediated by α5. Using pharmacological and siRNA-based experiments, we show that α5 is essential for nicotine-induced proliferation and migration. Additionally, upon downregulation of α5, nicotine-promoted expression of EMT markers and immune regulatory proteins was impaired. Moreover, the α5 polymorphism D398N (α5SNP) caused a basal increase in proliferation and migration in the DU145 cell line, and the effect was mediated through G-protein signaling. Taken together, our results indicate that nicotine-induced cancer cell proliferation and migration are mediated via α5, adding to the characterization of α5 as a putative therapeutical target.

[1]  A. Jemal,et al.  Cancer statistics, 2023 , 2023, CA: a cancer journal for clinicians.

[2]  Q. Zhang,et al.  Alpha5 nicotinic acetylcholine receptor mediated immune escape of lung adenocarcinoma via STAT3/Jab1-PD-L1 signalling , 2022, Cell Communication and Signaling.

[3]  U. Maskos,et al.  Divergent Roles of α5 and β4 Nicotinic Receptor Subunits in Food Reward and Nicotine-induced Weight Loss in Male Mice , 2022, Endocrinology.

[4]  W. Du,et al.  CHRNA5 Contributes to Hepatocellular Carcinoma Progression by Regulating YAP Activity , 2022, Pharmaceutics.

[5]  M. Lathrop,et al.  An innate contribution of human nicotinic receptor polymorphisms to COPD-like lesions , 2021, Nature Communications.

[6]  C. Peinelt,et al.  Investigation of Novel Small Molecular TRPM4 Inhibitors in Colorectal Cancer Cells , 2021, Cancers.

[7]  J. Minna,et al.  Nicotinic Acetylcholine Receptor Subunit α7 Mediates Cigarette Smoke-Induced PD-L1 Expression in Human Bronchial Epithelial Cells , 2021, Cancers.

[8]  G. Krasteva‐Christ,et al.  Nicotinic Acetylcholine Receptors in the Respiratory Tract , 2021, Molecules.

[9]  C. Bouzat,et al.  Tyrosine phosphorylation differentially fine-tunes ionotropic and metabotropic responses of human α7 nicotinic acetylcholine receptor , 2021, Cellular and Molecular Life Sciences.

[10]  R. Ostrom,et al.  Anti‐inflammatory effects of α7‐nicotinic ACh receptors are exerted through interactions with adenylyl cyclase‐6 , 2021, British journal of pharmacology.

[11]  Shih-Ying Wu,et al.  Nicotine promotes breast cancer metastasis by stimulating N2 neutrophils and generating pre-metastatic niche in lung , 2021, Nature Communications.

[12]  Ceren Sucularlı,et al.  CHRNA5 belongs to the secondary estrogen signaling network exhibiting prognostic significance in breast cancer , 2021, Cellular Oncology.

[13]  P. Scholze,et al.  The α5 Nicotinic Acetylcholine Receptor Subunit Differentially Modulates α4β2* and α3β4* Receptors , 2020, Frontiers in Synaptic Neuroscience.

[14]  M. Zoli,et al.  CHOLINE AND NICOTINE INCREASE GLIOBLASTOMA CELL PROLIFERATION BY BINDING AND ACTIVATING α7- AND α9- CONTAINING NICOTINIC RECEPTORS. , 2020, Pharmacological research.

[15]  C. Peinelt,et al.  Small molecular inhibitors block TRPM4 currents in prostate cancer cells, with limited impact on cancer hallmarks functions. , 2020, Journal of molecular biology.

[16]  O. Schmachtenberg,et al.  The interplay between α7 nicotinic acetylcholine receptors, pannexin‐1 channels and P2X7 receptors elicit exocytosis in chromaffin cells , 2020, Journal of neurochemistry.

[17]  T. Chou,et al.  Low-Dose Nicotine Activates EGFR Signaling via α5-nAChR and Promotes Lung Adenocarcinoma Progression , 2020, International journal of molecular sciences.

[18]  Wei Zhang,et al.  Nicotine promotes brain metastasis by polarizing microglia and suppressing innate immune function , 2020, The Journal of experimental medicine.

[19]  U. Maskos.  The nicotinic receptor alpha5 coding polymorphism rs16969968 as a major target in disease: Functional dissection and remaining challenges , 2020, Journal of neurochemistry.

[20]  Xiaoli Ma,et al.  α5‐nAChR contributes to epithelial‐mesenchymal transition and metastasis by regulating Jab1/Csn5 signalling in lung cancer , 2020, Journal of cellular and molecular medicine.

[21]  Y. Ho,et al.  The α9 Nicotinic Acetylcholine Receptor Mediates Nicotine-Induced PD-L1 Expression and Regulates Melanoma Cell Proliferation and Migration , 2019, Cancers.

[22]  Yan-ping Zhang,et al.  Cholinergic α5 nicotinic receptor is involved in the proliferation and invasion of human prostate cancer cells , 2019, Oncology reports.

[23]  C. Peinelt,et al.  TRPM4 is highly expressed in human colorectal tumor buds and contributes to proliferation, cell cycle, and invasion of colorectal cancer cells , 2019, Molecular oncology.

[24]  L. Jia,et al.  Dual blockage of both PD-L1 and CD47 enhances immunotherapy against circulating tumor cells , 2019, Scientific Reports.

[25]  F. Arnalich,et al.  Anti-tumoral activity of the human-specific duplicated form of α7-nicotinic receptor subunit in tobacco-induced lung cancer progression. , 2019, Lung cancer.

[26]  B. Lambolez,et al.  A Human Polymorphism in CHRNA5 Is Linked to Relapse to Nicotine Seeking in Transgenic Rats , 2018, Current Biology.

[27]  M. Pallavicini,et al.  α9‐ and α7‐containing receptors mediate the pro‐proliferative effects of nicotine in the A549 adenocarcinoma cell line , 2018, British journal of pharmacology.

[28]  M. Bizzarri,et al.  Nicotine increases colon cancer cell migration and invasion through epithelial to mesenchymal transition (EMT): COX‐2 involvement , 2018, Journal of cellular physiology.

[29]  M. Zoli,et al.  Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors , 2018, Current neuropharmacology.

[30]  R. Nichols,et al.  Beyond the Channel: Metabotropic Signaling by Nicotinic Receptors. , 2018, Trends in pharmacological sciences.

[31]  E. Sigel,et al.  α subunits in GABAA receptors are dispensable for GABA and diazepam action , 2017, Scientific Reports.

[32]  N. Kabbani,et al.  A G protein‐coupled α7 nicotinic receptor regulates signaling and TNF‐α release in microglia , 2017, FEBS open bio.

[33]  Xiaoli Ma,et al.  Reciprocal activation of α5-nAChR and STAT3 in nicotine-induced human lung cancer cell proliferation. , 2017, Journal of genetics and genomics = Yi chuan xue bao.

[34]  C. Fernández‐Capitán,et al.  Expression patterns for nicotinic acetylcholine receptor subunit genes in smoking-related lung cancers , 2017, Oncotarget.

[35]  M. Caron,et al.  Probing the Allosteric Role of the α5 Subunit of α3β4α5 Nicotinic Acetylcholine Receptors by Functionally Selective Modulators and Ligands. , 2017, ACS chemical biology.

[36]  C. Bouzat,et al.  Understanding the Bases of Function and Modulation of α7 Nicotinic Receptors: Implications for Drug Discovery , 2016, Molecular Pharmacology.

[37]  Hong-Zhuan Chen,et al.  Role of α7-nicotinic acetylcholine receptor in nicotine-induced invasion and epithelial-to-mesenchymal transition in human non-small cell lung cancer cells , 2016, Oncotarget.

[38]  P. Faure,et al.  Alterations in alpha5* nicotinic acetylcholine receptors result in midbrain- and hippocampus-dependent behavioural and neural impairments , 2016, Psychopharmacology.

[39]  E. Sigel,et al.  Novel positive allosteric modulators of GABAA receptors with anesthetic activity , 2016, Scientific Reports.

[40]  Pierre-Jean Corringer,et al.  Emerging Molecular Mechanisms of Signal Transduction in Pentameric Ligand-Gated Ion Channels , 2016, Neuron.

[41]  M. Skok,et al.  Nicotinic acetylcholine receptors in mitochondria: subunit composition, function and signaling , 2016 .

[42]  Xiaoli Ma,et al.  Nicotine Inhibits Cisplatin-Induced Apoptosis via Regulating α5-nAChR/AKT Signaling in Human Gastric Cancer Cells , 2016, PloS one.

[43]  Yumay Chen,et al.  Pemphigus vulgaris antibodies target the mitochondrial nicotinic acetylcholine receptors that protect keratinocytes from apoptolysis. , 2015, International immunopharmacology.

[44]  Xiaoli Ma,et al.  α5-nAChR modulates nicotine-induced cell migration and invasion in A549 lung cancer cells. , 2015, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

[45]  I. Thompson,et al.  Smoking and Prostate Cancer: A Systematic Review. , 2015, European urology focus.

[46]  J. Yakel,et al.  Activation of α7 nicotinic acetylcholine receptors increases intracellular cAMP levels via activation of AC1 in hippocampal neurons , 2015, Neuropharmacology.

[47]  Nadine Kabbani,et al.  Identification and Characterization of a G Protein-binding Cluster in α7 Nicotinic Acetylcholine Receptors* , 2015, The Journal of Biological Chemistry.

[48]  J. Yakel,et al.  Nicotinic ACh receptors as therapeutic targets in CNS disorders. , 2015, Trends in pharmacological sciences.

[49]  E. López-Collazo,et al.  A New IRAK-M-Mediated Mechanism Implicated in the Anti-Inflammatory Effect of Nicotine via α7 Nicotinic Receptors in Human Macrophages , 2014, PloS one.

[50]  N. Dang,et al.  α5 Nicotinic acetylcholine receptor mediates nicotine-induced HIF-1α and VEGF expression in non-small cell lung cancer. , 2014, Toxicology and applied pharmacology.

[51]  M. Damaj,et al.  The α4 Nicotinic Receptor Promotes CD4+ T-Cell Proliferation and a Helper T-Cell Immune Response , 2014, Molecular Pharmacology.

[52]  S. Chellappan,et al.  Nicotine-Mediated Cell Proliferation and Tumor Progression in Smoking-Related Cancers , 2014, Molecular Cancer Research.

[53]  Amarda Shehu,et al.  Are nicotinic acetylcholine receptors coupled to G proteins? , 2013, BioEssays : news and reviews in molecular, cellular and developmental biology.

[54]  J. Foekens,et al.  Loss of E-cadherin is not a necessity for epithelial to mesenchymal transition in human breast cancer , 2013, Breast Cancer Research and Treatment.

[55]  J. Stitzel,et al.  Impact of human D398N single nucleotide polymorphism on intracellular calcium response mediated by α3β4α5 nicotinic acetylcholine receptors , 2012, Neuropharmacology.

[56]  Edwin K Silverman,et al.  Genome-wide association studies identify CHRNA5/3 and HTR4 in the development of airflow obstruction. , 2012, American journal of respiratory and critical care medicine.

[57]  V. Tsetlin,et al.  Mitochondria Express α7 Nicotinic Acetylcholine Receptors to Regulate Ca2+ Accumulation and Cytochrome c Release: Study on Isolated Mitochondria , 2012, PloS one.

[58]  S. Cragg,et al.  Striatal α5 Nicotinic Receptor Subunit Regulates Dopamine Transmission in Dorsal Striatum , 2012, The Journal of Neuroscience.

[59]  E. Lambe,et al.  Nicotinic α5 Subunits Drive Developmental Changes in the Activation and Morphology of Prefrontal Cortex Layer VI Neurons , 2012, Biological Psychiatry.

[60]  H. Tricoire-Leignel,et al.  Emerging Pharmacological Properties of Cholinergic Synaptic Transmission: Comparison between Mammalian and Insect Synaptic and Extrasynaptic Nicotinic Receptors , 2011, Current neuropharmacology.

[61]  S. Navani,et al.  The human protein atlas , 2011 .

[62]  C. D. Fowler,et al.  Habenular α5* nicotinic receptor signaling controls nicotine intake , 2011, Nature.

[63]  Yu-Jia Chang,et al.  Nicotine Enhances Colon Cancer Cell Migration by Induction of Fibronectin , 2011, Annals of Surgical Oncology.

[64]  S. Iacobelli,et al.  An immunohistochemically positive E-cadherin status is not always predictive for a good prognosis in human breast cancer , 2010, British Journal of Cancer.

[65]  A. Tapper,et al.  The nicotinic acetylcholine receptor CHRNA5/A3/B4 gene cluster: Dual role in nicotine addiction and lung cancer , 2010, Progress in Neurobiology.

[66]  William Wheeler,et al.  Multiple Independent Loci at Chromosome 15q25.1 Affect Smoking Quantity: a Meta-Analysis and Comparison with Lung Cancer and COPD , 2010, PLoS genetics.

[67]  J. Warner,et al.  Role of α5 Nicotinic Acetylcholine Receptors in Pharmacological and Behavioral Effects of Nicotine in Mice , 2010, Journal of Pharmacology and Experimental Therapeutics.

[68]  B. Kupelnick,et al.  Smoking as a risk factor for prostate cancer: a meta-analysis of 24 prospective cohort studies. , 2010, American journal of public health.

[69]  Kevin J. Tracey,et al.  The Neurology of the Immune System: Neural Reflexes Regulate Immunity , 2009, Neuron.

[70]  Scott F. Saccone,et al.  Risk for nicotine dependence and lung cancer is conferred by mRNA expression levels and amino acid change in CHRNA5. , 2009, Human molecular genetics.

[71]  M. Skok.  Editorial: To channel or not to channel? Functioning of nicotinic acetylcholine receptors in leukocytes , 2009, Journal of leukocyte biology.

[72]  J. Changeux.  Nicotinic receptors and nicotine addiction. , 2009, Comptes rendus biologies.

[73]  K. Shianna,et al.  A Genome-Wide Association Study in Chronic Obstructive Pulmonary Disease (COPD): Identification of Two Major Susceptibility Loci , 2009, PLoS genetics.

[74]  H. Schuller.  Is cancer triggered by altered signalling of nicotinic acetylcholine receptors? , 2009, Nature Reviews Cancer.

[75]  Cecilia Gotti,et al.  Diversity of vertebrate nicotinic acetylcholine receptors , 2009, Neuropharmacology.

[76]  G. Gamble,et al.  Lung cancer gene associated with COPD: triple whammy or possible confounding effect? , 2008, European Respiratory Journal.

[77]  Margaret Sutcliffe,et al.  Epithelial–mesenchymal transition (EMT) is not sufficient for spontaneous murine breast cancer metastasis , 2008, Developmental dynamics : an official publication of the American Association of Anatomists.

[78]  C. Kirkpatrick,et al.  Acetylcholine beyond neurons: the non‐neuronal cholinergic system in humans , 2008, British journal of pharmacology.

[79]  G. Mills,et al.  Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1 , 2008, Nature Genetics.

[80]  Paolo Vineis,et al.  A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25 , 2008, Nature.

[81]  A. C. Collins,et al.  Nicotinic α5 subunit deletion locally reduces high‐affinity agonist activation without altering nicotinic receptor numbers , 2007, Journal of neurochemistry.

[82]  R. Langley,et al.  T Cells Express α7-Nicotinic Acetylcholine Receptor Subunits That Require a Functional TCR and Leukocyte-Specific Protein Tyrosine Kinase for Nicotine-Induced Ca2+ Response1 , 2007, The Journal of Immunology.

[83]  W. Wu,et al.  Nicotine promotes cell proliferation via alpha7-nicotinic acetylcholine receptor and catecholamine-synthesizing enzymes-mediated pathway in human colon adenocarcinoma HT-29 cells. , 2007, Toxicology and applied pharmacology.

[84]  M. Zoli,et al.  Brain nicotinic acetylcholine receptors: native subtypes and their relevance. , 2006, Trends in pharmacological sciences.

[85]  David John Adams,et al.  Selective Modulation of Neuronal Nicotinic Acetylcholine Receptor Channel Subunits by Go-Protein Subunits , 2005, The Journal of Neuroscience.

[86]  J. Massagué,et al.  Epithelial-Mesenchymal Transitions Twist in Development and Metastasis , 2004, Cell.

[87]  J. Changeux,et al.  Rational understanding of nicotinic receptors drug binding. , 2004, Current topics in medicinal chemistry.

[88]  J. Kawabe,et al.  Nicotinic acetylcholine receptor α7 regulates cAMP signal within lipid rafts , 2003 .

[89]  J. Changeux,et al.  The diversity of subunit composition in nAChRs: evolutionary origins, physiologic and pharmacologic consequences. , 2002, Journal of neurobiology.

[90]  G. Strathdee.  Epigenetic versus genetic alterations in the inactivation of E-cadherin. , 2002, Seminars in cancer biology.

[91]  A. Børresen-Dale,et al.  Re‐expression of E‐cadherin, α‐catenin and β‐catenin, but not of γ‐catenin, in metastatic tissue from breast cancer patients , 2000 .

[92]  K. Keyser,et al.  Assembly of Human Neuronal Nicotinic Receptor α5 Subunits with α3, β2, and β4 Subunits* , 1996, The Journal of Biological Chemistry.

[93]  J. Changeux,et al.  Molecular evolution of the nicotinic acetylcholine receptor: An example of multigene family in excitable cells , 1995, Journal of Molecular Evolution.

[94]  Kathleen A. Hinchman,et al.  Progression , 1896, Journal of Adolescent & Adult Literacy.

[95]  Lorna M. Lopez,et al.  Genome-Wide Association Studies Identify CHRNA5/3 and HTR4 in the Development of Airflow Obstruction , 2012 .

[96]  Qun Lu,et al.  Habenular a5 nicotinic receptor subunit signalling controls nicotine intake , 2011 .

[97]  H. Arias.  Positive and negative modulation of nicotinic receptors. , 2010, Advances in protein chemistry and structural biology.

[98]  M. Carless,et al.  Nicotine induces cell proliferation, invasion and epithelial‐mesenchymal transition in a variety of human cancer cell lines , 2009, International journal of cancer.

[99]  E. Albuquerque,et al.  Mammalian nicotinic acetylcholine receptors: from structure to function. , 2009, Physiological reviews.

[100]  Available online at: , 2007 .

[101]  C. Harris,et al.  Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells. , 2003, The Journal of clinical investigation.

[102]  J. Changeux,et al.  Nicotinic receptors at the amino acid level. , 2000, Annual review of pharmacology and toxicology.

[103]  M. Mareel,et al.  The E-cadherin/catenin complex in invasion and metastasis. , 1996, Current topics in microbiology and immunology.